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Abstract
Long lasting elevation is a key factor during endoscopic submucosal dissection
(ESD) and can be obtained by water jet injection of saline solution or by viscous
macromolecular solutions. In a previous animal study, we assessed the Nestis
Enki II system to combine jet injection and viscous solutions. In the present work,
we used this combination in humans in different sites of the digestive tract.
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Introduction
!
In expert hands, endoscopic submucosal dissec-
tion (ESD) is the method of choice to treat super-
ficial neoplastic lesions of the digestive tract lar-
ger than 20mm as it allows “en bloc” resection
[1,2]. Nonetheless, it carries a high perforation
rate andmay be a lengthy procedurewith numer-
ous changes of devices for elevation and dissec-
tion. Use of a water jet with a bifunctional (injec-
tion and cutting) catheter saves timewith a signif-
icant reduction in perforation risk [3,4]. In addi-
tion, injection of macromolecular solutions such
as a glycerol mixture or hyaluronic acid induces
long lasting elevation to perform ESD in a stable
situation [5]. Water jet injection of macromolecu-
lar solutions theoretically combines the advanta-
ges of both water jet and macromolecules but, so
far, available systems have not been able to inject
viscous solutions. The Nestis water jet allows
pulsed injection of macromolecules, even with
the endoscope retroflexed. This system has
shown its ability to inject hyaluronate, glycerol
mixture, or hydroxyethyl starch (HES) in pig
stomach [6]. In pig colon, it has demonstrated its
superiority versus conventional ESD (needle and
knife) in terms of safety issues [3]. In isolated pig
stomach, ESD using hyaluronate was quicker than
saline when both were injected by the water jet.
We now report retrospectively the first clinical
cases usingmacromolecular jet injection in differ-
ent sites of the digestive tract in four expert cen-
ters in France and Belgium between January 2013
and January 2014.
Material and methods
!
Water jet system and bifunctional catheter
The water jet system used in this study (Nestis®
Enki II®, Lyon, France) is not a pump like other
available water jets such as ERBE Jet® (ERBE®, Tü-
bingen, Germany), but it comprises a high pres-
sure chamber (●" Fig.1a) that can accommodate
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Background: Long lasting elevation is a key factor
during endoscopic submucosal dissection (ESD)
and can be obtained by water jet injection of sal-
ine solution or by viscous macromolecular solu-
tions. In a previous animal study, we assessed the
Nestis Enki II system to combine jet injection and
viscous solutions. In the present work, we used
this combination in humans in different sites of
the digestive tract.
Methods:We retrospectively report all of the con-
secutive ESD procedures performed with jet in-
jection of viscous solutions in four centers. Infor-
mation was collected about the lesion, the proce-
dure, the histological result, and the outcomes for
the patient.
Results: In total, 45 resections were completed by
six operators: five experts and one beginner with
only one previous experience in human ESD. Le-
sions were located in the esophagus (10), the
stomach (11), the duodenum (1), the colon (1)
and the rectum (22). Average maximal lesion di-
ameter was 4.8cm (SD 2.4, range 2–11cm), aver-
age lesion surface area was 19.8cm2 (SD 17.7,
range 2.2–72cm2), and average duration of pro-
cedure was 79.9min (SD 50.3min, range 19–225
min). ESD could be conducted while the endo-
scopewas retroflexed at its maximum in 26 cases.
Four adverse events were observed: two diminu-
tive perforations and two delayed bleeding occur-
rences treated conservatively. The R0 resection
rate was 91.1%. The catheter was obstructed in
six occurrences of bleeding.
Conclusion: Endoscopic submucosal dissection
using high pressure injection of viscous macro-
molecular solutions is safe and effective in differ-
ent parts of the digestive tract. It does not impede
working with the endoscope in the maximal ret-
roflexed position.
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and compress plastic bags of saline or viscous solutions. The pres-
sure in the chamber is obtainedwithmedical nitrogen and can be
set by the operator between 2 and 25 bars using a touchscreen. A
flexible tube is connected to the plastic bag in the chamber.This
tube passes through an electric clamp controlled by a foot pedal
before exiting the pressure chamber and is connected to the
cutting knife with a standard luer-lock connection (●" Fig.1b).
This system allows a pulsed injection that theoretically can im-
prove mucosal elevation by pulsing thanks to a hammer effect.
The Nestis® knife is a bifunctional catheter (injection through
the catheter and cutting with the electrode that is connected to
an electrosurgical generator) with a 2.3mm external diameter
sheath covering a retractable metal electrode 1.8mm long with
a distal plate of 1.2mm diameter. The injection hole is 200µm
wide and is central to the metal electrode (●" Fig.1c). In contrast
with Flushknife BT (DK2618JN, FUJIFILM®, Saitama, Japan), the li-
quid is injected under higher pressure at the distal part of the
catheter in the center of the plate and not around the electrode.
In contrast with other water jets available, the Nestis system is
able to inject macromolecular viscous solutions through a very
soft catheter (●" Fig.1d). Suction is thus preserved during the
procedure even on endoscopes with standard working channels
and its flexibility allows working in a retroflexed position with
smooth movements. The pressure used during the whole study
was 12 bars since this level was demonstrated to be effective to
obtain good elevation without any perforation during earlier
studies on living animals [6]. The injection is controlled by the
operator using a foot pedal and can be precisely chosen by the
physician. The activation and termination of the injection occur
immediately after the action on the pedal so the control of the
mucosal cushion is precisely determined by the operator himself
and avoids misunderstandings with the assistant. The system
also allows a precise volume to be injected, controlled by the op-
erator on the screen of the machine, but usually all of the opera-
tors prefer to control the mucosal cushion using the foot pedal
exactly as we do, whereas the assistant usually injects with the
needle.
Methods
We retrospectively included all of the consecutive patients who
underwent an ESD procedure between January 2013 and January
2014 using the Nestis® water jet system and with injection of a
macromolecular solution. The macromolecular solutions used
were: hydroxyethyl starch 130/0.4 (HES, Voluven®, Fresenius
Kabi®, France), a mixture of glycerol (glycerol 10%, fructose 5%,
and normal saline solution, produced by Edouard Herriot phar-
macy, Lyon), carboxymethyl cellulose solution, and Geloplasma®
(sodium lactate solution). In French centers, a glycerol mixture
(produced by Edouard Herriot hospital pharmacy) was the first
choice if available, and otherwise, we used HES.Hyaluronate was
not used in clinical practice for cost reasons.
ESD procedures
The choice of endoscope depended on the operator and the loca-
tion of the lesion but was always upper gastrointestinal scopes
for cases involving the rectum, esophagus, or stomach. All inter-
ventions were performed with a distal transparent hood at-
tached to the tip of the scope (4mm length with a 3mm hole,
D201-11304, Olympus®, Tokyo, Japan). The lateral margins of
the targeted neoplasia were determined by white light, narrow-
band imaging, and/or chromoendoscopy (using indigo carmine
spray for stomach and colon, acetic acid for Barrett’s lesion, and
iodine for squamous cell lesions). The tip of the Nestis® knife
was then used for marking if needed. Submucosal injection was
performed using the Nestis® knife: in the stomach, Barrett’s
esophagus, and colon, injection was possible directly by applying
the catheter against the mucosa, while in squamous cell esopha-
geal mucosa, injection was done through a previous coagulation
point. Submucosal injection of macromolecular solution colored
with indigo carmine blue was accomplished without a needle
using the Nestis® knife under 12 bars of pressure to obtain a
clearly visible mucosal elevation. We used the ERBE® VIO 200D
(ERBE®, Tübingen, Germany) electrosurgical unit with the follow-
ing settings:
▶ Soft coagulation, effect 4, 50W, for marking and hemostasis.
▶ Endocut mode I, effect 4, for circumferential incision.
▶ Swift coagulation, effect 3, 40W, for dissection.
a
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Fig.1 Nestis Enki II® system: a operating princi-
ples; b schematic injection in the submucosal tis-
sue, c catheter; d endoscopic view of the catheter
during an endoscopic submucosal dissection (ESD)
procedure.
Pioche Mathieu et al. High pressure injection of viscous solutions for ESD… Endosc Int Open 2015; 03: E368–E372
Original article E369
THIEME
D
ow
nl
oa
de
d 
by
: U
CL
 U
ni
ve
rs
ite
 C
at
ho
liq
ue
 d
e 
Lo
uv
ai
n.
 C
op
yr
ig
ht
ed
 m
at
er
ia
l.
Visible vessels were coagulated with the Nestis® knife, and larger
vessels were coagulated with diathermic forceps. Hemoclips
were only used in the case of failure of these techniques. Circum-
ferential cutting was performed totally or partially before be-
ginning ESD, and the tunnel method [7] could be used for esoph-
ageal dissection. For dissection, submucosal injection was per-
formed with the same technique as for circumferential cutting.
There was no limitation concerning the number and registered
volume of injections during the procedure. After endoscopic re-
moval of the specimen, the resected area was investigated for re-
sidual superficial vessels, which were then coagulated with the
Nestis® knife or, if necessary, with coagulation forceps. In the dif-
ferent centers involved in this study, the same strategy using one
needle type knife and a diathermic forceps for hemostasis is com-
mon including when using other devices such as the Dualknife®
(Olympus®, Tokyo, Japan) or FLushKnife® (Fujinon®, Tokyo, Ja-
pan). The choice of the diathermic forceps (Olympus®, Tokyo, Ja-
pan) to replace the Coagrasper® (Olympus, Tokyo, Japan) is justi-
fied for the cost effectiveness of the procedure in our countries
where a specific reimbursement for ESD does not exist.
The duration of the procedure corresponded to the period be-
tween the beginning of marking and the end of the procedure in-
cluding prophylactic hemostasis after lesion removal. Specimen
size was measured at the end of the procedure on the lesion
stretched on cork, and was defined by its two larger diameters
and its surface area using the formula for an ellipse: Area (cm2)=
(small diameter (cm)/2)×(large diameter (cm)/2)×π as used in
previous reports [6]. Dissection speed was defined as follows:
Speed (cm2/min)=area (cm2)/duration (min).
Adverse events
A perforation was a complete muscular layer opening, while an
incomplete muscle tear was defined as damage to the inner cir-
cular muscle layer. Perforation was immediate when diagnosed
during the procedure or delayed when discovered later after re-
covery. Delayed perforation was diagnosed by a computed to-
mography (CT) scan required by the patient’s symptoms (pain, fe-
ver, abdominal guarding).
Significant bleeding was defined as a hemoglobin level drop of
more than 2g/dL or ongoing clinically overt bleeding that requir-
ed endoscopic hemostasis and/or blood transfusion.
Preparation and pathology evaluation of the resected
specimen
Each resected specimen was gently stretched and fixed on cork
with needles immediately after lesion removal. Completeness of
the specimen including identification of themarking dots was as-
sessed. The specimen was stored in 4% neutral buffered formalin
for subsequent pathological evaluation. Separate expert patholo-
gists in each of the four centers performed pathology examina-
tion. The specimens were sectioned completely into 1.5-mm sli-
ces for evaluation of type and grade of neoplasia, vertical depth of
tumor invasion, and completeness of vertical (VM0) and horizon-
tal resection (HM0) of neoplasia or with tumor-infiltrated mar-
gins (R1), laterally (HM1), or deeply (VM1), and undetermined
margins due to coagulation artifacts or piecemeal resection (Rx,
HMx, VMx). In addition, permeation of lymphatic or blood ves-
sels was investigated.
“En bloc” resection was defined macroscopically as a one piece
complete resection of the superficial epithelial neoplastic lesion,
thus obtaining a single specimen for subsequent histological a-
nalysis. Piecemeal resection was defined as removal of the lesion
in at least two separate pieces.
R0 resection was defined as an “en bloc” resected lesion with tu-
mor-free lateral and in-depth resection margins at histological
examination. At histological examination, lesions with non-as-
sessable resection borders were termed Rx, whereas lesions
with resection margins in contact with pathological tissue were
termed R1. If the lesion could not be completely resected, the re-
section was termed R2 and considered to be an ESD procedure
failure [8].
Curative resection was defined as an R0 resection of a well differ-
entiated neoplastic lesion without vascular or lymphatic emboli.
Statistics
Data were collected prospectively using the same report form in
all of the four centers and then analyzed using descriptive statis-
tics (mean and standard deviation as well as mean and range).
Results (●" Table1)
!
Procedures (example,●" Fig.2)
In total, 45 patients underwent ESD (22 female, mean age 65.3
years (range 36–92)). Six endoscopists performed these proce-
dures (five experienced and one beginner in human ESD). All
procedures in the rectum and two in the gastric cardia were
mainly performed in retroflexion with no loss of jet power.
Among esophageal procedures, six were resected using the tun-
nel technique in two centers in Lyon and the others were per-
formed by the standard technique without submucosal tunnel-
ing.
Among the 45 procedures, 44 were endoscopically completewith
marking dots and one seemed complete but without macroscopic
margins. All resections were en bloc using only the Nestis® knife
in 40 cases, and other devices were used in five cases: IT knife 2®
(Olympus®, Tokyo, Japan) in one stomach case in Mermoz hospi-
Table 1 Results for the 45 procedures.
Number of procedures, n 45
Esophagus, n 10
Stomach, n 11
Duodenum, n 1
Ascending colon, n 1
Rectum, n 22
R0 resection
All, n (%) 41 (91.1)
Esophagus, n (%) 9 (90)
Stomach, n (%) 10 (90.9)
Duodenum, n (%) 1 (100)
Ascending colon, n (%) 1 (100)
Rectum, n (%) 20 (90.9)
Maximal diameter, mean (SD), cm 4.8 (2.4)
Duration, mean (SD), min 79.9 (50.3)
Area, mean (SD), cm2 19.8 (17.7)
Speed, mean (SD), cm2/min 0.27 (0.18)
Length of stay, mean (SD), days 2.8 (1.3)
Bubble around rectum, n (%) 2 (4.4)
Delayed bleeding occurrences, n (%) 2 (4.4)
Intraoperative perforation, n 0
Injection issues, n (%) 6 (13.3)
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tal, and the Dual knife® and IT knife 2® in four cases in Louvain.
Diathermy forceps (Hot biopsy forceps®, Olympus®, Tokyo, Japan)
were always used (n=45) for coagulation of large vessels, in the
case of bleeding during the procedure, or to perform the prophy-
lactic hemostasis after resection.
The procedures were performed by injecting different macromo-
lecular solutions: HES (n=25), glycerol mixture (n=14), Gelo-
plasma® (n=5), or carboxymethyl cellulose solution (n=1). Injec-
tion was always possible during the procedures apart from six
cases owing to a catheter obstruction. This occurred in bleeding
situations after a mean time of 58min (range 30–90min) due to
carbonization at the tip of the device. To finish the procedure in
these six cases, other devices were used in four cases (Dual Knife®
in one case, Dual Knife+ IT knife® in two cases, IT Knife 2® in one
case) and a new Nestis® catheter was used in the other two cases.
In four cases, installation of the cartridge in the electric clamp
was incorrect and damaged the tube before the beginning of the
procedure. Nevertheless, injection was possible after cartridge
replacement.
Bubbles appeared in the working field during the procedure
while using carboxymethyl cellulose solution (n=1, a significant
amount of foam) and Geloplasma® (n=5, a few bubbles) but they
were not reported with the glycerol mixture (n=14) or HES (n=
25).
The average time for the procedure was 79.9min (SD 50.3, range
19–225min). The average dissection speed was 0.27cm2/min
(SD 0.18, range 0.06–0.7cm2/min).
Lesions
Among the 45 specimens, the resections involved:
▶ 22 lateral spreading tumors of the rectum (LST) (five low grade
dysplasia (LGD), nine high grade dysplasia (HGD), six mucosal
carcinoma, one submucosal carcinomawith less than 1000µm
invaded (sm1), one submucosal carcinoma with less than
1000µm invaded (sm1) but with lymphatic emboli),
▶ 11 gastric lesions (three HGD, five mucosal carcinoma, two
fibroid inflammatory polyps, one hyperplastic polyp),
▶ 10 esophageal lesions (two mucosal squamous cell carcinoma
[SCC], eight lesions on Barrett's esophagus [BE] [six mucosal
carcinoma (one with ring cells), one HGD and one LGD]),
▶ 1 of the ascending colon (sessile serrated lesion HGD),
▶ 1 of the second duodenum (LGD) in Belgium.
The average maximal lesion diameter was 4.8cm (SD 2.4, range
2–11cm) and the average area was 19.8cm2 (SD 17.7, range
2.2–72cm2). In total, 41 (91.1%) of the 45 procedures resulted
in R0 resection with safe margins in depth (VM0) and laterally
(HM0). From the four remaining procedures, all four were R1 on
the lateral margin: the first two procedures by the unskilled op-
erator (focally for one rectal LST, on 5mm for the other rectal
LST), one fibroid inflammatory polyp without margin, one
esophageal adenocarcinoma with HGD margins.
Among the 45 lesions, 40 (88.9%) of the 41 R0 resections were
considered curative after pathology analysis since one lesion
presented lymphatic emboli.
Adverse events
No perforation occurred during the procedures. Four adverse
events were observed: two delayed diminutive perforations
(4.4%) and two delayed occurrences of bleeding. Concerning the
diminutive perforations, CT scans were indicated by an increase
in C reactive protein 24 hours after the procedure but without
any symptoms and demonstrated bubbles around the rectum.
The patients were treated conservatively with antibiotics for 7
days. The perforation rate was different according to the experi-
ence of the physician with 9.1% for the beginner (1/11) versus
4.2% for one expert and 0% for the others. The two occurrences
of bleeding were during the first 24 hours after a gastric ESD
procedure. Among them, one patient received a transfusion of
two blood units but encountered a spontaneous positive issue
without any new endoscopic procedure and one patient requir-
ed a second look endoscopy for successful endoscopic hemosta-
sis.
The average length of stay for patients who underwent ESD pro-
cedures was 2.8 days (SD 1.3, range 2–8 days).
Discussion
!
To the best of our knowledge, the new Nestis Enki 2® water jet
system is the first device able to inject both saline and macromo-
lecular solutions under high pressure through a single bifunc-
tional catheter. This first experience in humans showed that
such injection is effective, feasible, and safe. The cost of this de-
vice is not precisely known yet since Nestis® is a very small com-
pany looking for support. For the initial experience, the machine
was lent to the centers and the cost of the catheter was some-
where between that for Dual Knife® and Hybrid Knife® catheters.
Overall, we report a 91.7% R0 resection rate, no major side ef-
fects, only two cases with bubbles around the rectum and with-
out symptoms, and two delayed occurrences of bleeding. This is a
Fig.2 Images of a procedure using Nestis® for a
lateral spreading tumor (nongranular type) (LST-
NG) of the rectum: a after marking, before first in-
jection; b first injection through the mucosa; c first
cutting; d submucosal dissection; e end of dissec-
tion; f piece stretching.
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relatively low perforation rate (0% during the procedures) com-
pared to 18% in the first European series [9] and a good effective-
ness compared to a large series with a >90% R0 resection rate
[10,11], especially when we consider the lack of experience of
one of the six physicians.
This system was used in different parts of the digestive tract in-
cluding the ascending colon and duodenum without severe ad-
verse events. The number of colonic cases was low since colonic
ESD is still controversial in France compared with piecemeal
endoscopic mucosal resection (EMR) [12]. The duodenal case
was performed before the different reports warning about the
perforation risk of such a procedure [13,14] so new evaluation
with safer devices such as the Nestis® instrument should be con-
ducted in highly skilled hands.
This system allows a new combination of two important optimi-
zations: viscous solutions with a long lasting cushion effect and
powerful water jet injection. These two optimizations have
shown their own benefits in terms of safety and effectiveness in
previous animal studies [3,15]. Furthermore, the combined ben-
efit of this association was previously reported on pig stomach
with dissection speed significantly increased by 35% [6]. It seems
to be a safe and easy to use device for beginners since it reduces
the number of tool exchanges while retaining the benefits of the
injected viscous solutions. It also allows repeated injections im-
mediately before cutting.
Although the best solution is probably hyaluronate, its cost limits
its widespread use. If possible, a glycerol mixture seems to be a
good option since it has never produced renal failure and since
its viscosity is close to that of HES (3.4mPa.s versus 4.6mPa.s) [6].
In this work, injection was always possible in direct viewing and
retroflexion but some difficulties introducing the cartridge into
the machine were reported by nurses, and four incidents of tube
damage occurred during this preparation time. In some bleeding
situations, carbonization appeared at the tip of the device, which
can obstruct the hole. Cleaning of the distal tip with a wet com-
press and frequent repeated injections seem to increase device
lifetime.
Our study has some limitations, notably because it is a retrospec-
tive work with no comparative group using the standard tech-
nique or normal saline injection. The different tumor sites and
the different experiences of the operators are also limitations
when comparing speeds. Obstruction of the catheter occurred in
six cases and represents a limitation of this kind of device but fre-
quent injections and catheter tip cleaning may increase the knife
lifetime. Nevertheless, this is the first report of water jet injection
with macromolecular solutions in humans without any severe
adverse events and with good effectiveness. In the future, such
water jets may be used to inject viscous solutions with active
components to prevent stenosis, delay bleeding, or to promote
healing.
To summarize, the Nestis® Enki 2 system is the first jet injector
able to inject viscous macromolecular solutions through a flex-
ible bifunctional catheter even with a retroflexed endoscope.
Overall, it is an easy to use and safe device, even in unskilled
hands. It might be a good tool to proceed to after pig training. A
multicentric prospective study is now scheduled.
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